Steminent
is a California-based biopharmaceutical company that develops novel living cellular therapeutics for degenerative and life-threatening diseases... Read moreSteminent
is a California-based biopharmaceutical company that develops novel living cellular therapeutics for degenerative and life-threatening diseases... Read more
Chairman & CEO
Ling-Mei Wang
News
Apr 24, 2025
BioSpace
Steminent: Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
Jul 20, 2017
Blackbird
Press Release: Steminent : Cerebellar Ataxia Market Provides Top Level Analysis of Global Clinical Trials Market Which Helps In Identifying Key Business Opportunities
Steminent Competitors
1
2
3
4
5
6
7
8
9